Rheumatology

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  

Medical College of Wisconsin Rheumatology Division recent publications

 

Parperis K*, Carrera G, Baynes K, Mautz A, DuBois M, Cerniglia R, Ryan LM* **: The prevalence of chondrocalcinosis (CC) of the acromioclavicular (AC) joint on chest radiographs and correlation with calcium pyrophosphate dehydrate (CPPD) crystal deposition disease. Clin Rheumatol 32:1383-1386, 2013

Parperis KM*,  Ryan LM* **: An unusual cause of destructive monoarthritis. J Clin Rheum 19:225, 2013

Uzuki M*, Sawai T, Ryan LM* **, Rosenthal AK* **, Masuda I* **: Up-regulation of ANK expression in joint tissue in calcium pyrophosphate dehydrate crystal deposition disease (CPPD). J Rheum. In press.

Rosenthal AK* **, Gohr CM, Mitton-Fitzgerald E, Lutz MK, Dubyak GR, Ryan LM* **: The progressive ankylosis gene product ANK regulates extracellular AT levels in primary articular chondrocytes. Arthritis Res Ther. In press.

Ryan LM* **: Crystal-induced arthritides. Merck Manual Professional Edition. The Merck Manuals. 2013.

Rosenthal AK* **, Ryan LM* **:Non-pharmacologic and pharmacologic management of CPP crystal arthritis and BCP arthropathy and periarticular syndromes. In: Rheumatic Disease Clinics of North America. T Neogi ed. In press.

Becker MA, Ryan LM* **: Clinical manifestations and diagnosis of calcium pyrophosphate crystal deposition disease. In: UpToDate. Basow DS editor. UpToDate, Waltham, MA, 2013

Becker MA, Ryan LM* **: Treatment of calcium pyrophosphate crystal deposition disease. In: UpToDate. Basow DS editor. UpToDate, Waltham, MA, 2013

Becker MA, Ryan LM* **: Pathogenesis and etiology of calcium pyrophosphate crystal deposition disease. In: UpToDate. Basow DS editor. UpToDate. Waltham, MA, 2013

Gazeley DJ*, Cronin ME* **: Diagnosis and treatment of the idiopathic inflammatory myopathies. Ther Adv Musculoskel Dis. 2011.

Ruperto N, Hanrahan LM, Alarcon GS, Belmont HM, Brey RL, Brunetta P, Buyon JP, Cronin ME* **, Dooley MA et al. International consensus for a definition of disease flare in lupus. Lupus 20:453-462, 2011

McAlister WH, Coburn SP, Zerega JA, Ryan LM* **, Ericson KL, Hersh JH, Mumm S, Whyte MP: Hypophosphatasia: Skeletal presentation in utero of non-lethal disease (seventeen new cases and literature review). J Bone Min Res. J Bone Mineral Res, June 2011.

Rosenthal AK* **, Ryan LM* **: Calcium pyrophosphate deposition-there’s nothing “pseudo” about it! Nature Reviews Rheumatology 7:257-258, 2011

Arita NA, Pelaez D, Cheung HS**: Activation of the extracellular signal-regulated kinases 1 and 2 (ERK1/2) is needed for the TGF-induced chondrogenic and osteogenic differentiation of mesenchymal stem cells. Biochem & Biophys Res Commun 405:564-569, 2011

Becker MA, Ryan LM* **: Clinical manifestations and diagnosis of calcium pyrophosphate crystal deposition disease. In: UpToDate. Basow DS editor. UpToDate, Waltham, MA, 2011

Becker MA, Ryan LM* **: Treatment of calcium pyrophosphate crystal deposition disease. In: UpToDate. Basow DS editor. UpToDate, Waltham, MA, 2011

Becker MA, Ryan LM* **: Pathogenesis and etiology of calcium pyrophosphate crystal deposition disease. In: UpToDate. Basow DS editor. UpToDate. Waltham, MA, 2011

Rosenthal AK* **, Gohr CM, Ninomiya J, Wakim B.  Proteomic analysis of articular cartilage vesicles from normal and osteoarthritic cartilage.  Arthritis Rheum 63:401-411,2011

Costello JC* **, Rosenthal AK* **, Kurup IV, Masuda I* **, Medhora M, Ryan LM* **: Parallel regulation of extracellular ATP and inorganic pyrophosphate: Roles of growth factors, transduction modulators, and ANK. Conn Tissue Research 52:139-146, 2011

Nasse M, Mattson E, Gohr C, Rosenthal A* **, Ratti S, Giordano M, Hirschmugl C.  Biological kinetics under the microscope-pathologic mineralization, IRENI and in vivo capabilities, in Srinivasan, G (ed). Vibrational Spectroscopic Imaging for Biomedical Applications,  McGraw Hill Companies (in press), 2009

Rosenthal AK* **, Hempel D*, Kurup IV, Masuda I* **, Ryan LM* **: Purine receptors modulate chondrocyte extracellular inorganic pyrophosphate production. Osteoarthritis and Cartilage 18:1496-1501, 2010

Bartels CM, Bell CL, Shinki K, Rosenthal A* **, Bridges AJ.  Changing trends in serious extra-articular manifestations of rheumatoid arthritis among US Veterans.  Rheumatology 49:1670-1675,2010

Whyte MP, Wenkert D, McAlister WH, Mugahl MZ, Freemont AJ, Whitehouse R, Baildam EM, Coburn SP, Ryan LM* **, Mumm, S: Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia. J Bone Min Res 24:1493-1505, 2009

Pelaez D, Huang CY, Cheung HS**: Cyclic compression maintains viability and induces chondrogenesis of human mesenchymal stem cells in fibrin gel scaffolds. Stem Cell & Development 18:93-102, 2009

Mitton E, Gohr CM, McNally MT, Rosenthal AK* **.  Articular cartilage vesicles contain RNA. Biochem Biophys Res Commun 338: 533-8, 2009

Jubeck B*, Muth E, Gohr CM, Rosenthal AK* **. Type II collagen levels correlate with mineralization by articular cartilage vesicles. Arthritis Rheum 60: 2741-6, 2009

Huang CY, Pelaez D, Doninguez-Bendala J, Garcia-Godoy F, Cheung HS**: Regenerative Medicine 4:809-821, 2009

McCarthy GM* **, Cheung HS**: Point: Hydroxyapatite crystal deposition is intimately involved in the pathogenesis and progression of human osteoarthritis. Current Rheum Reports 11:141-147, 2009

Rosenthal AK* **, Terkeltaub, RA . CPPD Deposition Disease, Pearls and Myths.  In Stone, JH (ed). New York, NY: Springer, A Clinician’s Pearls and Myths in Rheumatology.  2009

Bartels C, Bell C, Rosenthal AK* **, Shinki K, Bridges A.  Decline in rheumatoid vasculitis prevalence among US Veterans: A retrospective cross-sectional study.  Arthritis Rheum 60:2553-7, 2009

Goyal R**: Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders. Current Opinion in Rheumatology. 2009, 21:78-84

Bartels C, Bell C, Rosenthal AK* **, Shinki K, Bridges A.  Decline in rheumatoid vasculitis prevalence among US Veterans: A retrospective cross-sectional study.  Arthritis Rheum 60:2553-7, 2009

Rosenthal AK* **, Gohr CM, Mitton E, Monnier VM, Burner T* **.  Advanced glycation end products increase transglutaminase activity in primary porcine tenocytes.  J Invest Med 57:460-6, 2009

Chung L, Shapiro L, Fiorentino D; Baron M, Shanahan J, Sule S, Hsu V, Rothfield N, Steen V, Martin RW, Smith E, Mayes M, Simms R, Pope J, Kahaleh B, Csuka ME* **, Gruber B, Collier D, Sweiss N, Gilbert A, Dechow FJ, Gregory J, Wigley FM.  MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud’s phenomenon: a randomized, controlled trial.  Arthritis Rheum 60: 870-7, 2009

Khanna D, Clements PJ, Furst DE, Korn JH, Ellman M, Rothfield N, Wigley FM, Moreland LW, Silver R, Kim YH, Steen VD, Firestein GS, Kavanaugh AF, Weisman M, Mayes MD, Collier D, Csuka ME* **, Simms R, Merkel PA, Medsger TA Jr, Sanders ME, Maranian P, Seibold JR. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 60:1102-11, 2009

Rosenthal AK* **. Osteoarthritis: The need for innovative therapeutic interventions. Curr Rheumatol Rev 5 (1): 3-7, 2009

Tehrani R, Ostrowski RA, Hariman R**, Jay WM.  Giant cell arteritis.  Seminars in Ophthalmology.  2008; 23:99-110.

Tehrani R, Ostrowski RA, Hariman R**, Jay WM.  Giant cell arteritis: Oral versus intravenous corticosteroids.  Neuro-Ophthalmology. 2009; 33: 5-9.

Tehrani R, Ostrowsk, RA, Hariman R**, Jay WM. Review of biologic therapies. Neuro-ophthalmology.  2009; 33:286-299

Alissa HM, Ostrowski RA, Hariman R**, Adams E.  Serum Sickness.  E-Medicine.  http://emedicine.medscape.com/article/332032-overview.  2009

Faust D, Halverson P* **, and Denson S: Rheumatology (Chs 46-54) In eds Torre DM, Lamb GC, Van Ruiswyk, J, Schapira RM, Kochar MS. In: Kochar’s Clinical Medicine for Students 5th ed., Lippincott, Williams & Williams, Baltimore, MD. 2009, pp 274-319

Burner T* **, Rosenthal AK* **. Diabetes and rheumatic diseases. Curr Opin Rheumatol 21: 50-4, 2009

Rosenthal AK* **, Mattson E, Gohr CM, Hirschmugl CJ.  Characterization of articular calcium-containing crystals by synchrotron FTIR. Osteoarthritis and Cartilage 16:1395-1402, 2008

Konon I* **, Cronin ME* **, Ryan LM* **: Acute inflammatory syndrome following introduction of Mycophenolate mofetil in a patient with systemic lupus erythematosus. Arthritis Care & Research. 59:754-756, 2008

Jubeck B*, Gohr CM, Fahey M*, Muth E, Matthews M, Mattson E, Hirschmugl C, Rosenthal AK* **. Promotion of articular cartilage matrix vesicle mineralization by type I collagen. Arthritis Rheum 58:2809-17, 2008

Tehrani R, Ostrowski RA, Hariman R**, Jay WM.  Ocular toxicity of hydroxychloroquine.  Seminars in Ophthalmology.  2008; 23:201-209

Muehleman C,  Li J, Aigner T,  Rappoport  L, Mattson  E, Hirschmugl CJ,  Masuda K, Rosenthal AK* **.  The association between crystals and cartilage degeneration in the ankle.  J Rheumatol 35:1108-17, 2008

Rosenthal AK* **, Fahey M*, Gohr C, Burner T* **, Konon I* **, Daft L, Mattson E, Hirschmugel C, Ryan LM* **, Simkin P: Feasibility of a tetracycline-binding method for detecting synovial fluid basic calcium phosphate crystals. Arthritis Rheum 58:3270-3274, 2008

Halverson PB* **, Ryan LM* **: Tidal lavage in Milwaukee Shoulder Syndrome: Do crystals make the difference? J Rheumatol 34:1446-1447, 2007

Rosenthal, AK* **. The role of non-collagenous proteins in mineralization.  Curr Opin Ortho 18:449-53, 2007

Major ML, Cheung HS**, Misra RP: Basic calcium phosphate crystals activate c-Fos expression through a Ras/ERK dependent signaling mechanism. Biochem & Biophys Res Commun 355:654-660, 2007

Gazi H, Pope JE, Clements P, Medsger TA, Martin RW, Merkel PA, Kahaleh B, Wollheim FA, Baron M, Csuka ME* **, Emery P, Belch JF, Hayat S, Lally EV, Korn JH, Czirjak L, Herrick A, Voskuyl AE, Bruehlmann P, Inanc M, Furst DE, Black C, Ellamn MH, Moreland L, Rothfield NF, Myes M, Mckown KM, Kreig T, Siebold JR. Outcome measures in scleroderma: results of a Delphi exercise. J Rheumatol 34(3): 501-9, 2007

Weihrauch D, Xu H, Shi Y, Wang J, Brien J, Jones DW, Kaul S, Komorowski RA, Csuka ME* **, Oldham KT, Pritchard Jr KA. Effects of D-4F vasodilation, oxidative stress, angiostatin, myocardial inflammation and angiogenic potential in Tight-skin mice. Am J Physiol Heart Circ Physiol 293:H1432-H1441, 2007

Rosenthal, AK* **. Update in Calcium Deposition Diseases. Curr Opin Rheum 19:158-62, 2007

Huang CY, Deitzer MA, Cheung HS**: Effects of fibrinolytic inhibitors on chondrogenesis of bone marrow-derived mesenchymal stem cells in fibrin gels. Biomechanics & Modeling in Mechanobiology 6:5-11, 2007

Rosenthal, AK* **.  Calcium Crystal Deposition and Osteoarthritis. Rheum Dis Clin N Amer 32: 401-12, 2006

Gohr CM, Fahey M*, Rosenthal AK* **. Calcific tendonitis: A model.  Conn Tiss Res 48:286-91, 2007

Rosenthal AK**, Gohr, CM Uziki M, Masuda I* **. Osteopontin promotes pathologic mineralization in articular cartilage. Matrix Biology 26:96-105 2007

Rosenthal AK* **. Pseudogout: Presentations, Natural History, and Associated Conditions in Wortmann RL**, Schumacher HR, Becker MA, Ryan LM* ** (eds). Crystal-Induced Arthropathies: Gout, Pseudogout and Apatite Associated Syndromes. 99-117, 2006

Jaovisidha J*, Ryan LM* **: Clinical manifestations of basic calcium phosphate (apatite) deposition disease. In: Crystal-Induced Arthropathies: Gout, Pseudogout, and Apatite-Associated Syndromes. Wortmann RL**, Schumacher HR, Becker MA, Ryan LM* ** editors. Taylor and Francis Group, New York, NY, 117-134, 2006

Wu JY, Sun Y, Graham DY, Cheung HS**, Yamaoka Y: Balance between polyoma enhancing activator 3 and activator protein regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression. Cancer Res 66:511105120, 2006

Ryan LM* **, Carrera GF**: Radiographic changes of crystal-induced arthropathy. In: Crystal-Induced Arthropathies: Gout, Pseudogout, and Apatite-Associated Syndromes. Wortmann RL**, Schumacher HR, Becker MA, Ryan LM* ** editors. Taylor and Francis Group, New York, NY, 173-188, 2006

Ryan LM* **, Costello JC* **: Biochemistry of calcium pyrophosphate dihydrate deposition. In: Crystal-Induced Arthropathies: Gout, Pseudogout, and Apatite-Associated Syndromes. Wortmann RL**, Schumacher HR, Becker MA, Ryan LM* ** editors. Taylor and Francis Group, New York, NY, 213-226, 2006

Halverson P.B* **. Other methods of crystal identification. Crystal-induced Arthropathies -  Gout, Pseudogout, and Apatite-associated Syndromes. Eds. Wortmann RL**, Schumacher Jr., H.R., Becker, M.A., Ryan, L.M.* ** Taylor & Francis, 2006, pp169-172

Wortmann RL**, Ryan LM* **: Management of crystal-induced arthropathies.  In: Crystal-Induced Arthropathies: Gout, Pseudogout, and Apatite-Associated Syndromes. Wortmann RL**, Schumacher HR, Becker MA, Ryan LM* ** editors. Taylor and Francis Group, New York, NY, 321-340, 2006

McCarty DJ**: Crystal-induced arthropathies—Historical perspectives. In: Crystal-Induced Arthropathies: Gout, Pseudogout, and Apatite-Associated Syndromes. Wortmann RL**, Schumacher HR, Becker MA, Ryan LM* ** editors. Taylor and Francis Group, New York, NY, 213-226, 2006

Cheung HS**: Biological effects of calcium-containing crystals. In: Crystal-Induced Arthropathies: Gout, Pseudogout, and Apatite-Associated Syndromes. Wortmann RL**, Schumacher HR, Becker MA, Ryan LM* ** editors. Taylor and Francis Group, New York, NY, 213-226, 2006

Cheung HS**: Therapeutic strategies for calcium-containing crystal arthropathies. In: Crystal-Induced Arthropathies: Gout, Pseudogout, and Apatite-Associated Syndromes. Wortmann RL**, Schumacher HR, Becker MA, Ryan LM* ** editors. Taylor and Francis Group, New York, NY, 213-226, 2006

webmaster@mcw.edu
© 2014 Medical College of Wisconsin
Page Updated 10/14/2013